AB1761-HPR A TELE-MONITORING PROGRAM FOR TIGHT CONTROL OF TREATMENT SAFETY IN PATIENTS WITH RHEUMATIC DISEASES

Background Initiation of an immuno-modulatory treatment is a vulnerable part the patient journey. Distance monitoring via reported outcomes (PROs) and wearables are used to assess efficacy. In combination with remote vital sign measurement tele-nursing, care may also increase safety save resources. However, it unclear how such telemedicine services integrate into clinical workflow. Objectives Feasibility User Experience (UX) study combined app-based nurse-assisted tele-monitoring program in rheumatic patients different risk profiles starting new biologic treatment. Methods this quantitative qualitative study, we explored distance service including contactless optical tele-nursing ambulatory Switzerland. System Usability Scores (SUS) semi-structured interviews were performed patients, tele-nurses, rheumatologists. Patients collected weekly PROs signs app (Vtuls, Switzerland) after instruction by tele-nurses. Vital deterioration triggered automated notification (categorized yellow, green, red) allowing corrective actions. Rheumatologists received monthly summaries PRO PDF form. Results 15 rheumatoid arthritis or spondylarthritis mean age 43.9 years (32-79) included monitored up three months phone calls tele-nurse. 15/15 found useful, mainly for staying contact their rheumatologist therapy start switch. 13/15 measured regularly, adherence questionnaires was significantly lower. 6 had technical problems blood pressure measurement. The generated average 16 alarms per patient, those 7.1 1.1 yellow 2.2 red alarms. rheumatologists considered as especially one high-level comorbidity who experienced infection another dosing error number consultations (e.g. routine control 1-2 treatment) lower cohort compared without care. reports email suboptimal digital integration workflow needs be implemented future versions program. Tele-nurses high comorbidity, shorter disease duration younger most suitable control. False initially increased workload nurses, but later reduced through advice adjustment thresholds. SUS scores slightly higher (median 97.5) tele-nurses 77.5). One outlier (17.5) expectations responsiveness based on entered PROs. Conclusion Tight efficacy app, biosensor appreciated all stakeholders, comorbidity. A better data communication required, ideally electronic medical record. rheumatology clinic observed, complete reorganization processes necessary. REFERENCES: NIL. Acknowledgements: Disclosure Interests Marco Fedeli: None declared, Jas Saini Shareholder of: Board directors at Vtuls, Henrik Ibsen director Opentelehealth, Miriam James Employee Mediservice AG, Thomas Hügle Scientific board member Consultant GSK, Novartis, Medac., Grant/research support from: Fresenius Kabi, Eli Lilly, Abbvie.